Macrophage cholesterol depletion and its effect on the phagocytosis of Cryptococcus neoformans

Arielle M Bryan1, Amir M Farnoud1, Visesato Mor1

  • 1Department of Molecular Genetics and Microbiology, Stony Brook University.

Insights

Cholesterol depletion significantly reduced the phagocytic index of macrophages infected with Cryptococcus neoformans. This study provides a protocol to investigate host sterols in Cryptococcus infections.

Area of Science:

  • Mycology
  • Immunology
  • Cell Biology

Background:

  • Cryptococcosis, a fungal infection caused by *Cryptococcus* species, can lead to fatal meningoencephalitis.
  • Macrophage phagocytosis is a key mechanism in *Cryptococcus* dissemination and pathogenesis.
  • Understanding host-pathogen interactions is crucial for developing effective treatments.

Purpose of the Study:

  • To establish a protocol for studying *Cryptococcus neoformans* macrophage infectivity in vitro.
  • To investigate the role of host sterols, specifically cholesterol, in macrophage-fungal interactions.

Main Methods:

  • Murine macrophage-like cell line J774A.1 was treated with methyl-β-cyclodextrin (MCD) to deplete cellular cholesterol.
  • Cholesterol depletion was confirmed using a cholesterol quantification kit and thin-layer chromatography.
  • Cells were activated with Lipopolysaccharide (LPS) and Interferon gamma (IFNγ) before infection with *C. neoformans* H99 at a 1:1 effector-to-target ratio.

Main Results:

  • Cholesterol depletion was successfully achieved and quantified.
  • Cholesterol-depleted macrophages exhibited a significantly reduced phagocytic index when infected with *C. neoformans*.
  • This suggests a critical role for host cholesterol in macrophage-mediated phagocytosis of *Cryptococcus*.

Conclusions:

  • The developed protocol offers a reliable method for in vitro study of *Cryptococcus* infection initiation.
  • Host cholesterol levels play a significant role in modulating macrophage phagocytic activity against *C. neoformans*.
  • Targeting host lipid metabolism may represent a novel therapeutic strategy against cryptococcosis.